CEP
SGYP

Chicago Equity Partners’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Chicago Equity Partners’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-472,535
Closed -$803K – 920
2018
Q3 		$803K Buy
472,535
+286,135
+154% +$512K 0.02% 572
2018
Q2 		$324K Buy
+186,400
New +$322K 0.01% 726
2017
Q2 		– Sell
-44,210
Closed -$206K – 892
2017
Q1 		$206K Buy
+44,210
New +$256K 0.01% 700

Other funds holding SGYP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Chicago Equity Partners's SGYP Position: Q4 2018 in Review

Chicago Equity Partners sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 472,535 shares — an estimated $803K sold.

Chicago Equity Partners first reported a position in SGYP in Q1 2017 and held it in 3 quarters. The position peaked at $803K in Q3 2018. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

  • Chicago Equity Partners reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
  • Chicago Equity Partners sold 472,535 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $803K.
  • Chicago Equity Partners first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2017 and held it in 3 quarters.
  • Chicago Equity Partners's Synergy Pharmaceuticals, Inc Common Stock position peaked at $803K in Q3 2018.
  • 89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on Chicago Equity Partners's 13F filing for Q4 2018, filed 5 Feb 2019.